This R01 grant opportunity supports clinical studies involving orphan products that address unmet needs in rare diseases. Clinical trials are required. The funding is provided by the Food and Drug Administration with a deadline of May 19, 2026. Specific eligibility and funding amount details are not provided.
Eligibility details are not specified in the grant listing. Contact the funding organization for requirements.
